Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy.
Although intravesical bacillus Calmette-Guerin (BCG) administration is an effective method in the treatment of superficial urinary bladder carcinoma, some complications may arise such as a granulomatous reaction either in the urinary tract or, in rare cases, outside the urinary tract. We report in this paper a case of granulomatous hepatitis following intravesical BCG administration.
Ozbakkaloglu
B
B
Department of Infectious Disease, Celal Bayar University, School of Medicine, Manisa, Turkey.
Tünger
O
O
Sürücüoglu
S
S
Lekili
M
M
Kandiloglu
A R
AR
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy; D006099:Granuloma / Q000209:etiology* / Q000473:pathology; D006505:Hepatitis / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine